The federal and B.C. governments are contributing millions of dollars to expand the capacity of a B.C. company to manufacture new antibody therapies, conduct research and carry out clinical trials. AbCellera CEO Dr. Carl Hansen talks about the importance of the investments in a Wed. May 24, 2023 press conference in Vancouver.
Health
B.C. biotech company expanding capacity with help from federal, provincial funds
More Videos
-
Former BC Women’s Hospital Foundation employee talks about needing hospital’s NICU
-
Health Matters: Speech & Hearing Month
-
Health-care workers lose COVID-19 vaccination court case
-
Miniscule payout for LifeLabs class action lawsuit claimants
-
Saturna Island family share story of ALS loss
-
Customers involved in LifeLabs data breach class-action lawsuit surprised by payout
You are viewing an Accelerated Mobile Webpage.
View Original Article